OneFund LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

OneFund LLC’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$216K	Sell	278 -23	-8%	-$17.6K	0.14%	134
2025 Q4	$232K	Buy	301 +17	+6%	+$11.5K	0.14%	126
2025 Q3	$160K	Buy	284 +10	+4%	+$5.65K	0.1%	172
2025 Q2	$144K	Buy	+274	New	+$153K	0.1%	179
2024 Q4	–	Sell	-278	Closed	-$292K	–	131
2024 Q3	$292K	Buy	278 +2	+0.7%	+$2.23K	0.3%	85
2024 Q2	$290K	Buy	276 +2	+0.7%	+$1.94K	0.32%	83
2024 Q1	$266K	Sell	274 -10	-4%	-$9.51K	0.32%	91
2023 Q4	$249K	Buy	+284	New	+$234K	0.32%	95

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

OneFund LLC's REGN Position: Q1 2026 in Review

OneFund LLC reduced its Regeneron Pharmaceuticals (REGN) stake by 7.6% in Q1 2026, selling an estimated $17.6K and leaving 278 shares worth $216K. The position accounts for 0.14% of the portfolio, ranked #134.

OneFund LLC first reported a position in REGN in Q4 2023 and has held it in 8 quarters since. The position peaked at $292K in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

OneFund LLC held 278 shares of Regeneron Pharmaceuticals worth $216K as of Q1 2026.
OneFund LLC sold 23 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $17.6K.
Regeneron Pharmaceuticals made up 0.14% of OneFund LLC's portfolio in Q1 2026, its #134 holding.
OneFund LLC first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
OneFund LLC's Regeneron Pharmaceuticals position peaked at $292K in Q3 2024.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on OneFund LLC's 13F filing for Q1 2026, filed 8 May 2026.